Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication ...

European Union antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings’ acquisition of contract drug ...

The FDA urges healthcare professionals to stop administering the products, and patients should stop using them.

She could go to a med-spa, but that would cost about $1,000 a month, still too much for the new therapist ... it became the ...

Read More: No One Knows How to Talk About Weight Loss ... are approved) and obesity (the target of Wegovy and Zepbound). They ...

The Phase 3 findings position semaglutide to become the first drug of its kind for the liver disease. But they also confirm ...

Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval ...

North Carolinians have many reasons to care about new ... arthritis. Diet and exercise alone are rarely successful in ...

Lizzo is getting in on the joke with a new Halloween costume that spoofs a bit from 'South Park: The End of Obesity.' ...